Biodesix Inc.

0.67
-0.04 (-6.00%)
At close: Mar 28, 2025, 3:58 PM
0.74
9.65%
Pre-market: Mar 31, 2025, 07:00 AM EDT

Biodesix Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Net Income -42.93M -52.15M -65.45M -43.16M -31.35M -30.73M -26.17M
Depreciation & Amortization 5.46M 5.51M 5.84M 3.18M 2.9M 2.79M 1.74M
Stock-Based Compensation 6.64M 5.37M 5.96M 4.94M 3.71M 170K 142K
Other Working Capital -21.52M 15.34M -2.98M -6.86M 5.51M 791K 446K
Other Non-Cash Items 3.86M 7.09M 13.01M 4.33M 6.58M 5.32M 6.31M
Deferred Income Tax n/a n/a n/a -2.1M 1.6M 2.36M 47K
Change in Working Capital -21.67M 11.3M -4.34M 4.59M -4.8M -1.65M 253K
Operating Cash Flow -48.65M -22.87M -44.97M -28.22M -21.37M -21.73M -17.68M
Capital Expenditures -3.23M -23.06M -3.53M -2.55M -2.18M -1.42M -617K
Acquisitions n/a n/a n/a n/a -750K -456K n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies -210K -143K -236K -306K -232K -106K -119K
Investing Cash Flow -3.44M -23.06M -3.53M -2.55M -2.93M -1.87M -617K
Debt Repayment -51K 9.95M 16.5M -15.35M 16.04M 13.04M -12.65M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -3.52M -8.95M -17.15M 269K -6.91M 19.93M 31.68M
Financial Cash Flow 52.05M 29.13M 58.88M 1.26M 81.13M 22.97M 19.03M
Net Cash Flow -39K -16.8M 10.38M -29.51M 56.84M -626K 738K
Free Cash Flow -51.88M -45.93M -48.51M -30.77M -23.54M -23.14M -18.29M